Skip to main content
. 2020 Dec 27;36(1):345–361. doi: 10.1080/14756366.2020.1864630

Table 3.

Antiproliferative activity in vitro of compounds with strong telomerase inhibitory activity (IC50<1 μM) against A375, MDA-MB-231, MGC-803, SMMC-7721 and SGC-7901 cell linesa.

  IC50 (μM)b
Compounds A375 MDA-MB-231 MGC-803 SMMC-7721 SGC-7901
A2 11.03 ± 1.54 25.06 ± 2.10 17.26 ± 2.21 8.07 ± 1.30 56.91 ± 1.24
A5 20.09 ± 0.62 c 15.22 ± 0.41 25.36 ± 0.59
A16 10.09 ± 0.52
A20 8.92 ± 0.69 19.50 ± 1.00 6.29 ± 0.36 10.22 ± 0.65
A27
A33 11.21 ± 0.69 9.89 ± 0.44 8.76 ± 0.25 9.67 ± 0.82 10.01 ± 0.51
B27
B33
BIBR1532 d 57.58 ± 0.21
ADM d 0.58 ± 0.20 0.51 ± 0.12 0.42 ± 0.08 0.79 ± 0.13 0.82 ± 0.43

Negative control 0.1% DMSO, no activity.

aThe data represented the mean of three experiments in triplicate and were expressed as means ± SD.

bThe IC50 value was defined as the concentration at which 50% survival of cells was observed. The results are listed in the table.

cNot observed in the tested concentration range (>100 μM).

dUsed as a positive control.